- Needle biopsy, a minimally invasive procedure for obtaining tissue samples for diagnostic purposes, is increasingly vital in modern healthcare for accurate disease diagnosis and treatment planning in both oncology and other medical fields, due to its precision, reduced patient discomfort, and rapid results
- The escalating demand for needle biopsy is primarily fueled by the widespread rise in cancer incidence, growing preference for less invasive diagnostic methods, and advancements in imaging guidance technologies
- North America dominates the needle biopsy market with the largest revenue share of 36.8% in 2024, characterized by advanced healthcare infrastructure, high incidence of chronic diseases, and a strong presence of key industry players
- Asia-Pacific is expected to be the fastest growing region in the needle biopsy market during the forecast period, with a CAGR of 7.38%, due to increasing healthcare expenditure, rising awareness about early disease diagnosis, and a large patient pool
- The needle-based biopsy guns segment dominates the needle biopsy market with a market share of 62% in 2024, driven by its precise control, accuracy in tissue acquisition, and efficiency in procedures
